Gongadze N V, Antelava N A, Kezeli T D
Georgian Med News. 2008 Jul-Aug(160-161):44-7.
An increasing number of studies suggest that the pharmacology and therapeutic potential of a family of imidazoline receptors continues to generate substantial interest of investigators. This review analyzes the functional role of imidazoline receptors, their subpopulation, distribution in the central and peripheral nervous system and action of related ligands. Besides to their brainstem location where I1-receptor sites play a significant role to regulate and modulate blood pressure, they also are found in different parts of brain with the highest densities in the striatum, pallidum, hippocampus, amygdala, substantia nigra, while I3-receptor sites were revealed in pancreas which enhances insulin secretion, I2-receptors are widely distributed in interpeduncular nucleus, arcuate and pineal gland and take a part in monoamine turnover. It is conclusion that imidazoline receptor in near future can become a therapeutic target in the treatment of diabetes, stroke, mood disorders and hyperalgesic condition.
越来越多的研究表明,一类咪唑啉受体的药理学特性和治疗潜力持续引发研究人员的浓厚兴趣。本综述分析了咪唑啉受体的功能作用、其亚群、在中枢和外周神经系统中的分布以及相关配体的作用。除了在脑干的位置(I1受体位点在调节和调控血压方面发挥重要作用)外,它们还存在于大脑的不同部位,纹状体、苍白球、海马体、杏仁核、黑质中的密度最高,而在胰腺中发现了I3受体位点,其可增强胰岛素分泌,I2受体广泛分布于脚间核、弓状核和松果体,并参与单胺代谢。结论是,咪唑啉受体在不久的将来可能成为治疗糖尿病、中风、情绪障碍和痛觉过敏病症的治疗靶点。